Online first
Current issue
Archive
Special Issues
About the Journal
Publication Ethics
Anti-Plagiarism system
Instructions for Authors
Instructions for Reviewers
Editorial Board
Editorial Office
Contact
Reviewers
All Reviewers
2023
2022
2021
2020
2019
2018
2017
2016
General Data Protection Regulation (RODO)
REVIEW PAPER
Weight training and appropriate nutrient supplementation as an alternative method to pharmacological treatment in rehabilitation of post-myocardial infarction patients
1
University of Maria Curie-Skłodowska, Lublin, Poland
2
Department of Zoonoses, Institute of Rural Health, Lublin, Poland
Ann Agric Environ Med. 2012;19(3):333-338
KEYWORDS
ABSTRACT
The article describes the impact of weight training, micro-elements and vitamins on rehabilitation in post-myocardial infarction patients. Cardiac rehabilitation is a multi-disciplinary and multi-faceted intervention aimed at restoring well-being and retarding disease progression in patients with heart disease. It has been shown that exercise-based cardiac rehabilitation is effective in reducing total and cardiovascular mortality. Intake of vitamins and other diet supplements was reported to exert beneficial effects. Pharmacological medication is associated with an increased risk of severe arrhythmia, and many adverse outcomes. Therefore, since conventional medicine only relieves the symptoms, cellular nutrition should be used in order to improve the quality of life in post-myocardial infarction patients. These elements prevent another infarction. The following nutrients are reported to have beneficial effects on general and cardiovascular health: amino acids, vitamins, coenzyme Q10, pycnogenol, inositol, omega-3 fatty acids, macromineral elements, and trace mineral elements. In conclusion, the review indicates that appropriate weight training and diet supplementation ensure full recovery and elimination of risk factors for cardiovascular diseases.
REFERENCES (56)
1.
Zatoński WA and the HEM project team. Epidemiological analysis of health situation development in Europe and its causes until 1990. Ann Agric Environ Med. 2011; 18: 194-202.
2.
Zatoński WA, Mańczuk M and Kielce PONS team. POlish-Norwegian Study (PONS): research on chronic non-communicable diseases in European high risk countries – study design. Ann Agric Environ Med. 2011; 18: 203-206.
3.
Islami F, Mańczuk M, Vedanthan R, Vatten L, Polewczyk A, Fuster V, Boffetta P, Zatoński WA. A cross-sectional study of cardiovascular disease and associated factors. Ann Agric Environ Med. 2011; 18: 255-259.
4.
Szuba A, Martynowicz H, Zatońska K, Ilow R, Regulska-Ilow B, Różańska D, Wołyniec M, Einhorn J, Vatten L, Asvold BO. Prevalence of hypertension in a sample of Polish population – baseline assessment from the prospective cohort ‘Pons’ study. Ann Agric Environ Med. 2011; 18: 260-254.
6.
Boyle P. Improving health in Central and Eastern Europe. Ann Agric Environ Med. 2011; 18: 281-282.
8.
Broda G, Rywik S, Kuriata P et al.. Zachorowalność na zawał serca oraz śmiertelność w zawale serca w populacji prawobrzeżnej Warszawy. Program Pol-Monica. Kardiol Pol. 1994; 41: 381.
9.
Rudnicki S. Cardiac rehabilitation post myocardial infarction and coronary intervention. Medicina Sportiva 2001; 5 (supl.2): 159-169.
10.
Rudnicki S. Rehabilitacja w chorobie niedokrwiennej serca. In: Gieca L (ed.). Choroba niedokrwienna serca. Warszawa, PZWL 1999, p. 409.
11.
Opolski G, Filipiak K, Polański L. Ostre zespoły wieńcowe. Wrocław, Urban Partner 2004.
12.
Kuch J, Rudnicki S. Rehabilitacja w chorobach układu sercowo-naczyniowego. In: Kuch J (ed.) Rehabilitacja. Warszawa, PZWL 1989, pp. 23-65.
13.
Thompson DR, Lewin RJP. Management of the post-myocardial infarction patient: rehabilitation and cardiac neurosis. Heart 2000; 84: 101-105.
14.
Davies EJ, Moxham T, Rees K, Singh S, Coats AJ, Ebrahim S, Lough F, Taylor RS. Exercise-based rehabilitation for heart failure. Cochrane Database Syst Rev. 2010; Apr 14 (4): CD003331.
15.
Heran BS, Chen JM, Ebrahim S, Moxham T, Oldridge N, Rees K, Thompson DR, Taylor RS. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2011; Jul 6(7): CD001800.
16.
Carrero JJ, Fonolla J, Marti JL, Jimenez J, Boza JJ, López-Huertas E. Intake of fish oil, oleic acid, folic acid, and vitamins B-6 and E for 1 year decreases plasma C-reactive protein and reduces coronary heart disease risk factors in male patients in a cardiac rehabilitation program. J Nutr. 2007; 137: 384-390.
17.
Dr George Jacob. Heart attack. Myocardial Infarction Diet/Nutrition for Heart Attack. Available in: holistic-online.com/Remedies/heart/heart_attack_diet-nutrition.htm.
19.
Rath M, Pauling L: Solution to the puzzle of human cardiovascular disease: Its primary cause is ascorbate deficiency leading to the deposition of lipoprotein (a) and fibrinogen/fibrin in the vascular. J Orthomolecular Med. 1991; 6: 125-134.
20.
Rath M: Reducing the risk for cardiovascular disease with nutritional supplements. J Orthomolecular Med. 1992; 7: 153-162.
21.
Ilow R, Regulska-Ilow B, Różańska D, Zatońska K, Dehghan M, Zhang X, Szuba A, Vatten L, Janik-Koncewicz K, Manczuk M, Zatoński WA. Evaluation of mineral and vitamin intake in the diet of a sample of Polish population – baseline assessment from the prospective cohort ‘Pons’ study. Ann Agric Environ Med. 2011; 18: 235-240.
22.
Łobaszewski J, Przewoźniak K, Zatońska K, Wojtyła A, Bylina J, Mańczuk M, Zatoński WA. Patterns of leisure time physical activity and its determinants among a sample of adults from Kielce region, Poland. Ann Agric Environ Med. 2011; 18: 241-245.
23.
Rath M. Lipoprotein reduction by ascorbate. J Orthomolecular Med. 1992; 7: 81-82.
24.
Rizzon P, Biasco G, Biaze M, Boscia F, Rizzo V, Minafra F, Bortone A, Siliprandi N, Procopio A, Bagiella E, Corzi M. High doses of L-carnitine in acute myocardial infarction: metabolic and antiarrhythmic effects. Eur Heart J. 1989; 10: 502-508.
26.
Korbut R. Effect of L-arginine on plasminogen-activator inhibitor in hypertensive patients with hypercholesterolemia. New Engl J Med. 1993; 328: 287-288.
27.
Ferrari R, Cucchini I, Wisioli O. The metabolical effects of L-carnitine in angina pectoris. Int J Cardiol. 1984; 5: 213-216.
28.
Ghidini O, Azzurro M, Vita A, Sartori G. Evaluation of the therapeutic efficacy of L-carnitine in congestive heart failure. Int J Clin Pharmacol Ther Toxicol. 1988; 26: 217-220.
29.
Lorenço R, Camilo ME. Taurine: a conditionally essential amino acid in humans? An overwiew in health and disease. Nutr Hosp. 2002; 17: 262-270.
30.
Office of the Dietary Supplements. National Institutes of Health. Dietary Supplement Fact Sheets. Available from: http://ods.od.nih.gov./factshe....
31.
Ross CA Vitamin A. In: Coates PM, Betz JM, Blackman MR et al (eds.) Encyclopedia of Dietary Supplements, 2 nd ed. Informa Healthcare 2010, London and New York, pp. 115-120.
32.
Shimon J, Almog S, Vered Z. et al. Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy. Am J Med. 1995; 98: 5.
33.
Riemersma RA, Wood DA, Macintyre CCA, Elton RA, Gey KF, Oliver MF. Risk of angina pectoris and plasma concentrations of vitamins A, C and E and carotene. Lancet 1991; 337: 1-5.
35.
Naurath HJ, Yoosten E, Riezler R. Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations. Lancet 1995; 346: 85-89.
36.
Gerster H. Potential role of beta-carotene in the prevention of cardiovascular disease. Int J Vitamin Nutr Res. 1991; 61: 277-291.
37.
Hemila H. Vitamin C and plasma cholesterol. In: Critical Reviews in Food Science and Nutrition 32(1): 33-57. Boca Raton, Florida, CRC Press Inc. 1992.
38.
Lavie CJ. Marked benefit with sustained-release niacin (Vit.B3) therapy in patients with isolated very low levels of high-density lipoprotein cholesterol and coronary artery disease. Am J Cardiol. 1992; 69: 1083-1085.
39.
Robinson K, Arheart K. Refsum H et al. Low circulatory folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. Circulation 1998; 97: 437-443.
40.
Koch ET. Effect of Vitamin C on blood parameters of hypertensive subjects. Oklahoma State Med Assoc J. 1984; 77: 177-182.
41.
Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC, National Academy Press, 2010.
42.
Rimm EB, Stampfer MJ, Ascherio AA, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. New Engl J Med. 1993; 328: 1449-1450.
43.
Folkers K, Ymammamura Y: Biomedical and clinical aspects of coenzyme Q. New York, Elsevier Science Publishers 1986: 1-5.
44.
Folkers K, Vandhanavikit S, Mortensen SA. Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q-10. Proc Nat Acad Sci. 1985; 82: 901-904.
45.
Folkers K, Langsioen P, Willis R, Richardson P, Xia LJ, Ye CQ, Tamagawa H. Lavastatin decreases coenzyme Q-10 levels in humans. Proc Nat Acad Sci. 1990; 87: 8331-8934.
46.
Kamikava T, Kabayashi A, Emaciate T, Hayashi H, Yamazaki N. Effects of coenzyme Q-10 on exercise tolerance in chronic stable angina pectoris. Am J Cardiol. 1985; 56: 247-251.
47.
Langsioen PH, Folkers K, Lyson K, Muratsu K, Lyson T, Langsioen P. Effective and safe therapy with coenzyme Q-10 for cardiomyopathy. Klin Wschr. 1988; 66: 583-590.
48.
Watson RR. Pycnogenol and cardiovascular health. Evidence-Based Integrative Med. 2003; 1: 27-32.
53.
Iseri LT, French JH. Magnesium: Nature’s physiologic calcium blocker. Am Heart J. 1984; 108: 188-193.
54.
Brown KM, Arthur JR. Selenium, selenoproteins and human health: a review. Public Health Nutr. 2001; 4: 593-599.
55.
Carson T. What are the health benefits of molybdenum. http://www. livestrong.com/article/36102-what-are-the-health-benefits-of-molybdenum.
56.
Vital Health Zone. All About Minerals. Molybdenum. Available from: http://www.vitalhealthzone.com....
Share
RELATED ARTICLE
| eISSN: | 1898-2263 |
| ISSN: | 1232-1966 |
Improvement of visual identification of the journal - task financed under the agreement No. 618/P-DUN/2019 by the Minister of Science and Higher Education allocated to the activities of disseminating science.
Generation of the DOI (Digital Object Identifier) - task financed under the agreement No. 618/P-DUN/2019 by the Minister of Science and Higher
© 2006-2024 Journal hosting platform by Bentus
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
